Language selection

Search

Royalty payments and Canada's Access to Medicines Regime A pharmaceutical company that holds a compulsory licence under Canada's Access to Medicines Regime is required to pay royalties to the patent holder. The company must make payments within a prescribed amount of time and in accordance with a prescribed formula. 2020-09-17 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyCanada's Access to Medicines Regimecompany that holds a compulsory licencepatent holderRoyalty payments. Royalty payments and Canada's Access to Medicines RegimeHTML https://www.canada.ca/en/health-canada/services/canada-access-medicines-regime/companies/application-process/royalty-payments.html Royalty payments and Canada's Access to Medicines RegimeHTML https://www.canada.ca/fr/sante-canada/services/regime-canadien-acces-medicaments/entreprises/processus-demande/versement-redevances.html

Royalty payments and Canada's Access to Medicines Regime

A pharmaceutical company that holds a compulsory licence under Canada's Access to Medicines Regime is required to pay royalties to the patent holder. The company must make payments within a prescribed amount of time and in accordance with a prescribed formula.

Resources

Resource Name Resource Type Format Language Links
Royalty payments and Canada's Access to Medicines Regime Publication HTML English Access
Royalty payments and Canada's Access to Medicines Regime Publication HTML French Access
Similar records